Double-Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) versus Oral Oxybutynin in SCI Patients with NDO (11-09-10-04). Annual Report September 30, 2012-September 29, 2014
(Englisch)
Bitte wählen Sie ihr Lieferland und ihre Kundengruppe
No subjects have been treated as yet. Recruitment at Michael E. DeBakey VAMC has been difficult due to eligibility criteria. Dr. Smith has completed the application to open patient recruitment to a new site with a large spinal cord injury population, The Institute of Rehabilitation and Research (TIRR). He has just become credentialed and the IRB process will begin immediately. Enrollment will begin as quickly as possible.
Double-Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) versus Oral Oxybutynin in SCI Patients with NDO (11-09-10-04). Annual Report September 30, 2012-September 29, 2014